October 7, 2021

COVID-19

Coronavirus COVID-19

A vaccine against coronavirus: how quickly it can create

Still not managed to develop a vaccine against the coronavirus. Probably up to 2021 it also will not. Here are the reasons.

As actually developed the vaccine?

There are two phases that can be roughly distinguished in the development process. In the first stage, a candidate vaccine tested on animals. The researchers checked what the active ingredients can move animals, what is the active ingredient reacts to the virus, but also create the correct antibodies. If this is enough, only then the vaccine will be tested on humans.

It will take some time to go through the whole procedure. Only after all this is completed, you can apply for admission.

What is the process from application to approval of the vaccine?

Researchers can, at least in the EU, to apply for approval to the European medical Agency. It registers all vaccines in the EU. The results of the study are carefully studied, and then is an assessment of how well a vaccine worked. If it meets the requirements, the Committee for medicinal products for human use would vote if he could be allowed or not. The Committee includes one member from each EU country.

All it takes is about seven months. Even if there is no time, as in the case of coronavirus COVID-2019, the procedure to be shortened to a maximum of two months. Thus, the whole process in the EU always takes five months.

This means that the finished vaccine we still have to wait until 2021.

Of course there are many scientists worldwide who are trying to find a suitable vaccine against coronavirus.

But no one is in the clinical phase, which means that nobody currently does not investigate the vaccine on humans. The vaccine so far tested only on animals.

There is also a new procedure in which individual institutions operate not with the actual virus, and only with certain genetic information. It makes the process much faster. In the United States, the company is working with this new procedure and therefore close to the clinical phase.

This means that it will be not only the first vaccine against the coronavirus, but the first vaccine created by a completely new process.

error: Content is protected !!